Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Medela Potentia TbkISX:MDLA -0.95%13 5-Year Yield-on-Cost % is 6.06 as of Aug. 11, 2026, which is 36% above its 10-year median of 4.45. GuruFocus rates ISX:MDLA with a GF Score™ of 13/100. The stock has 2 warning signs investors should review. Among 70 Medical Distribution companies, PT Medela Potentia Tbk ranks better than 75.71% on this metric.
PT Medela Potentia Tbk's yield on cost for the quarter that ended in Jun. 2026 was 6.06.
The historical rank and industry rank for PT Medela Potentia Tbk's 5-Year Yield-on-Cost % or its related term are showing as below:
ISX:MDLA'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 3.48 Med: 4.45 Max: 6.18
Current: 6.06
During the past 5 years, PT Medela Potentia Tbk's highest Yield on Cost was 6.18. The lowest was 3.48. And the median was 4.45.
ISX:MDLA's 5-Year Yield-on-Cost % is ranked better than 75.71% of 70
companies
in the Medical Distribution industry
Industry Median: 3.155
vs ISX:MDLA: 6.06
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
PT Medela Potentia Tbk 5-Year Yield-on-Cost % Related Terms
ISX:MDLA vs MCK, COR, CAH: 5-Year Yield-on-Cost % Comparison
For the Medical Distribution subindustry, PT Medela Potentia Tbk's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Medela Potentia Tbk 5-Year Yield-on-Cost % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Medela Potentia Tbk's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where PT Medela Potentia Tbk's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
PT Medela Potentia Tbk (ISX:MDLA) has a 5-Year Yield-on-Cost % of 6.06 as of Aug. 11, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on PT Medela Potentia Tbk and its competitors. This is 36% above median its historical median of 4.45. Over the past decade, PT Medela Potentia Tbk's 5-Year Yield-on-Cost % has ranged from 3.48 to 6.18. According to the industry distribution chart, PT Medela Potentia Tbk ranks #17 out of 70 companies in the Medical Distribution industry, placing it in the top 24.3%.
Is PT Medela Potentia Tbk's 5-Year Yield-on-Cost % too high?
PT Medela Potentia Tbk's current 5-Year Yield-on-Cost % of 6.06 is 36% above median its 10-year median of 4.45. Over the past 10 years, this metric has ranged from a low of 3.48 to a high of 6.18. The Medical Distribution industry median 5-Year Yield-on-Cost % is 3.16. PT Medela Potentia Tbk's value of 6.06 is 92.1% above this industry median. Based on the distribution chart, PT Medela Potentia Tbk ranks #17 out of 70 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, PT Medela Potentia Tbk has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does PT Medela Potentia Tbk's 5-Year Yield-on-Cost % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, PT Medela Potentia Tbk ranks #17 out of 70 companies for 5-Year Yield-on-Cost %. This places PT Medela Potentia Tbk in the top 24% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 3.16. PT Medela Potentia Tbk's value of 6.06 is 92.1% above this benchmark. Historically, PT Medela Potentia Tbk's own 5-Year Yield-on-Cost % has ranged from 3.48 to 6.18 over the past decade. While the company's 10-year median is 4.45 vs. the industry median of 3.16, PT Medela Potentia Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Distribution company?
The median 5-Year Yield-on-Cost % among Medical Distribution companies is 3.16, based on 70 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Medela Potentia Tbk's current 5-Year Yield-on-Cost % of 6.06 is 92.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on PT Medela Potentia Tbk and its competitors. For the Medical Distribution industry, the median 5-Year Yield-on-Cost % is 3.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Medela Potentia Tbk's current 5-Year Yield-on-Cost % is 6.06, which is 36% above median its own 10-year median of 4.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Medela Potentia Tbk stock overvalued right now?
PT Medela Potentia Tbk (ISX:MDLA) has a current 5-Year Yield-on-Cost % of 6.06. The current 5-Year Yield-on-Cost % is 6.06, which is 36% above median its 10-year median of 4.45 and 92.1% above the Medical Distribution industry median of 3.16. PT Medela Potentia Tbk's overall GF Score™ is 13/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For PT Medela Potentia Tbk (ISX:MDLA), the current 5-Year Yield-on-Cost % is 6.06 as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT Medela Potentia Tbk is a healthcare-focused holding company engaged in pharmaceutical distribution, medical device manufacturing, and marketing services. It is engaged in the distribution and marketing of pharmaceutical products, health products, and medical devices. It also manufactures medical devices and implements web portals and digital platforms for commercial purposes through its subsidiaries. The Company manages three main operating segments, namely pharmaceutical products, healthcare products, and medical devices.
13GF Score
Get the complete analysis for ISX:MDLA
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:MDLA has been successfully added to your 
